Introducing “Hepatitis B Virus: Prevention and Care” by Tarek I. Hassanein MD. In collaboration with consulting editor Dr. Norman Gitlin, Dr. Tarek Hassanein has gathered a team of top experts in hepatology to provide the most current information on the topic of Hepatitis B Virus. This comprehensive issue covers everything from the global perspective on HBV infections to the impact of HBV on liver transplantation and much more. Whether you are a healthcare professional looking to stay up-to-date or someone who has been directly affected by HBV, this book is a valuable resource.

Hepatitis B Virus (HBV) is a viral infection that affects the liver. It can cause both acute and chronic hepatitis, and it is a major global health problem. In fact, according to the World Health Organization (WHO), approximately 257 million people worldwide are living with chronic HBV infection. These numbers highlight the importance of understanding HBV, its prevention, and the care of infected patients.

The issue starts by discussing the global perspective on HBV infections in the era of effective vaccines. Vaccination has been a crucial tool in controlling the spread of HBV, and this article provides an overview of the current state of vaccination programs worldwide. It also explores the challenges that still exist in certain regions and populations.

Understanding the natural history of HBV infection is essential for effective prevention and care. The issue delves into the new definitions of cure and the endpoints of clinical trials. This is crucial for healthcare professionals as it guides the treatment decisions and helps set realistic goals for patients with HBV infection.

HBV/HCV coinfection is another important topic covered in this issue. The advent of highly effective direct-acting antiviral agents (DAAs) for HCV has revolutionized the treatment landscape. However, the interaction between HBV and HCV infections can complicate the treatment approach. This article explores the challenges and potential solutions.

Antiretroviral effects on HBV/HIV coinfection and the natural history of liver disease is also a key focus. Coinfection with HIV and HBV is common due to similar routes of transmission. The issue explores the specific challenges faced by individuals with both infections and how antiretroviral therapy can impact the natural history of liver disease.

HBV infection can have a significant impact on hepatocellular carcinoma (HCC) and liver transplantation. These topics are thoroughly discussed, providing insights into the relationship between HBV and these conditions and the management strategies that need to be implemented.

Pregnant women and their infants are not exempt from the effects of HBV infection. This issue explores the implications of HBV infection during pregnancy and the measures that can be taken to ensure the health and wellbeing of both the mother and child.

The World Health Organization (WHO) guidelines for prevention, care, and treatment of individuals infected with HBV are also presented in this issue. These guidelines help healthcare professionals in their decision-making process and ensure that standardized and evidence-based care is provided.

Reconciling the differences between the major HBV treatment guidelines is a challenge. The American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Asian Pacific Association for the Study of the Liver (APASL) have slightly different recommendations. This article aims to bring clarity to these differences and provide guidance on the best course of action.

HBV/HDV coinfection, a challenge for therapeutics, is also covered in this book. HDV is a defective RNA virus that requires the presence of HBV for its replication and transmission. This article explores the challenges faced in treating individuals with both infections and the potential strategies that can be employed.

Finally, the issue explores the effects of hepatic steatosis on the natural history of HBV infection. Hepatic steatosis, also known as fatty liver disease, is characterized by the buildup of fat in the liver. This article discusses the implications of hepatic steatosis on HBV infection and the potential impact on disease progression.

Readers of “Hepatitis B Virus: Prevention and Care” will come away with the most current information needed to effectively manage patient outcomes. Whether you are a healthcare professional looking to expand your knowledge or an individual directly affected by HBV, this book is an invaluable resource. Order your copy today and stay informed about the latest advancements in the prevention and care of Hepatitis B Virus.

Product Details

• Publisher: Elsevier; 1st edition (July 17, 2019)
• Language: English
• ISBN-10: 0323682286
• ISBN-13: 978-0323682282